$GNCA Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in GENOCEA BIOSCIENCES, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in GENOCEA BIOSCIENCES, INC.. Get notifications about new insider transactions in GENOCEA BIOSCIENCES, INC. for free.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 15 2014 | GNCA | GENOCEA BIOSCIENCE ... | Hoffman Eric S | Chief Business Offi ... | Option Exercise | A | 8.41 | 205,053 | 1,724,496 | 205,053 | |
| Sep 15 2014 | GNCA | GENOCEA BIOSCIENCE ... | Flechtner Jessica Baker | VP of Research | Option Exercise | M | 2.38 | 56 | 133 | 3,228 | |
| Sep 15 2014 | GNCA | GENOCEA BIOSCIENCE ... | Flechtner Jessica Baker | VP of Research | Option Exercise | M | 2.38 | 1,456 | 3,465 | 3,284 | |
| Sep 15 2014 | GNCA | GENOCEA BIOSCIENCE ... | Flechtner Jessica Baker | VP of Research | Option Exercise | M | 1.67 | 420 | 701 | 0 | |
| Sep 15 2014 | GNCA | GENOCEA BIOSCIENCE ... | Flechtner Jessica Baker | VP of Research | Option Exercise | M | 1.67 | 1,680 | 2,806 | 0 | |
| Sep 15 2014 | GNCA | GENOCEA BIOSCIENCE ... | Flechtner Jessica Baker | VP of Research | Option Exercise | M | 2.38 | 3,663 | 8,718 | 4,740 | |
| Sep 15 2014 | GNCA | GENOCEA BIOSCIENCE ... | Flechtner Jessica Baker | VP of Research | Option Exercise | M | 1.67 | 840 | 1,403 | 0 | |
| Sep 15 2014 | GNCA | GENOCEA BIOSCIENCE ... | Flechtner Jessica Baker | VP of Research | Sell | S | 12.00 | 56 | 672 | 1,680 | 1.7 K to 1.7 K (-3.23 %) |
| Sep 15 2014 | GNCA | GENOCEA BIOSCIENCE ... | Flechtner Jessica Baker | VP of Research | Buy | M | 2.38 | 56 | 133 | 1,736 | 1.7 K to 1.7 K (+3.33 %) |
| Sep 15 2014 | GNCA | GENOCEA BIOSCIENCE ... | Flechtner Jessica Baker | VP of Research | Sell | S | 12.00 | 1,456 | 17,472 | 1,680 | 3.1 K to 1.7 K (-46.43 %) |
| Sep 15 2014 | GNCA | GENOCEA BIOSCIENCE ... | Flechtner Jessica Baker | VP of Research | Buy | M | 2.38 | 1,456 | 3,465 | 3,136 | 1.7 K to 3.1 K (+86.67 %) |
| Sep 15 2014 | GNCA | GENOCEA BIOSCIENCE ... | Flechtner Jessica Baker | VP of Research | Sell | S | 12.00 | 420 | 5,040 | 1,680 | 2.1 K to 1.7 K (-20.00 %) |
| Sep 15 2014 | GNCA | GENOCEA BIOSCIENCE ... | Flechtner Jessica Baker | VP of Research | Buy | M | 1.67 | 420 | 701 | 2,100 | 1.7 K to 2.1 K (+25.00 %) |
| Sep 15 2014 | GNCA | GENOCEA BIOSCIENCE ... | Flechtner Jessica Baker | VP of Research | Buy | M | 1.67 | 1,680 | 2,806 | 1,680 | 0 to 1.7 K |
| Sep 15 2014 | GNCA | GENOCEA BIOSCIENCE ... | Flechtner Jessica Baker | VP of Research | Sell | S | 12.00 | 3,663 | 43,956 | 0 | 3.7 K to 0 (-100.00 %) |
| Sep 15 2014 | GNCA | GENOCEA BIOSCIENCE ... | Flechtner Jessica Baker | VP of Research | Buy | M | 2.38 | 3,663 | 8,718 | 3,683 | 20 to 3.7 K (+18,315.00 %) |
| Sep 15 2014 | GNCA | GENOCEA BIOSCIENCE ... | Flechtner Jessica Baker | VP of Research | Sell | S | 12.00 | 840 | 10,080 | 0 | 840 to 0 (-100.00 %) |
| Sep 15 2014 | GNCA | GENOCEA BIOSCIENCE ... | Flechtner Jessica Baker | VP of Research | Buy | M | 1.67 | 840 | 1,403 | 840 | 0 to 840 |
| Sep 15 2014 | GNCA | GENOCEA BIOSCIENCE ... | Giannasca Paul | VP of Development | Option Exercise | M | 2.02 | 4,071 | 8,223 | 4,259 | |
| Sep 15 2014 | GNCA | GENOCEA BIOSCIENCE ... | Giannasca Paul | VP of Development | Sell | S | 11.84 | 4,071 | 48,201 | 0 | 4.1 K to 0 (-100.00 %) |
| Sep 15 2014 | GNCA | GENOCEA BIOSCIENCE ... | Giannasca Paul | VP of Development | Buy | M | 2.02 | 4,071 | 8,223 | 4,071 | 0 to 4.1 K |
| Sep 15 2014 | GNCA | GENOCEA BIOSCIENCE ... | BATE KENNETH | Director | Option Exercise | A | 12.00 | 10,084 | 121,008 | 10,084 | |
| Sep 10 2014 | GNCA | GENOCEA BIOSCIENCE ... | Giannasca Paul | VP of Development | Option Exercise | M | 2.02 | 834 | 1,685 | 8,330 | |
| Sep 10 2014 | GNCA | GENOCEA BIOSCIENCE ... | Giannasca Paul | VP of Development | Option Exercise | M | 2.02 | 2,455 | 4,959 | 9,164 | |
| Sep 10 2014 | GNCA | GENOCEA BIOSCIENCE ... | Giannasca Paul | VP of Development | Option Exercise | M | 2.02 | 2,970 | 5,999 | 11,619 | |
| Sep 10 2014 | GNCA | GENOCEA BIOSCIENCE ... | Giannasca Paul | VP of Development | Sell | S | 12.35 | 834 | 10,300 | 0 | 834 to 0 (-100.00 %) |
| Sep 10 2014 | GNCA | GENOCEA BIOSCIENCE ... | Giannasca Paul | VP of Development | Buy | M | 2.02 | 834 | 1,685 | 834 | 0 to 834 |
| Sep 10 2014 | GNCA | GENOCEA BIOSCIENCE ... | Giannasca Paul | VP of Development | Sell | S | 12.43 | 2,455 | 30,516 | 0 | 2.5 K to 0 (-100.00 %) |
| Sep 10 2014 | GNCA | GENOCEA BIOSCIENCE ... | Giannasca Paul | VP of Development | Buy | M | 2.02 | 2,455 | 4,959 | 2,455 | 0 to 2.5 K |
| Sep 10 2014 | GNCA | GENOCEA BIOSCIENCE ... | Giannasca Paul | VP of Development | Sell | S | 12.80 | 2,970 | 38,016 | 0 | 3 K to 0 (-100.00 %) |
| Sep 10 2014 | GNCA | GENOCEA BIOSCIENCE ... | Giannasca Paul | VP of Development | Buy | M | 2.02 | 2,970 | 5,999 | 2,970 | 0 to 3 K |
| Sep 04 2014 | GNCA | GENOCEA BIOSCIENCE ... | Clark William D | President and CEO | Option Exercise | M | 2.86 | 20,000 | 57,200 | 19,807 | |
| Sep 04 2014 | GNCA | GENOCEA BIOSCIENCE ... | Clark William D | President and CEO | Buy | M | 2.86 | 20,000 | 57,200 | 20,000 | 0 to 20 K |
| Sep 04 2014 | GNCA | GENOCEA BIOSCIENCE ... | Giannasca Paul | VP of Development | Option Exercise | M | 2.86 | 5,398 | 15,438 | 12,157 | |
| Sep 04 2014 | GNCA | GENOCEA BIOSCIENCE ... | Giannasca Paul | VP of Development | Sell | S | 12.51 | 5,398 | 67,529 | 0 | 5.4 K to 0 (-100.00 %) |
| Sep 04 2014 | GNCA | GENOCEA BIOSCIENCE ... | Giannasca Paul | VP of Development | Buy | M | 2.86 | 5,398 | 15,438 | 5,398 | 0 to 5.4 K |
| Aug 29 2014 | GNCA | GENOCEA BIOSCIENCE ... | Giannasca Paul | VP of Development | Option Exercise | M | 2.86 | 855 | 2,445 | 17,555 | |
| Aug 29 2014 | GNCA | GENOCEA BIOSCIENCE ... | Giannasca Paul | VP of Development | Option Exercise | M | 2.86 | 4,602 | 13,162 | 18,410 | |
| Aug 29 2014 | GNCA | GENOCEA BIOSCIENCE ... | Giannasca Paul | VP of Development | Option Exercise | M | 2.86 | 1,303 | 3,727 | 23,012 | |
| Aug 29 2014 | GNCA | GENOCEA BIOSCIENCE ... | Giannasca Paul | VP of Development | Sell | S | 12.86 | 855 | 10,995 | 0 | 855 to 0 (-100.00 %) |
| Aug 29 2014 | GNCA | GENOCEA BIOSCIENCE ... | Giannasca Paul | VP of Development | Buy | M | 2.86 | 855 | 2,445 | 855 | 0 to 855 |
| Aug 29 2014 | GNCA | GENOCEA BIOSCIENCE ... | Giannasca Paul | VP of Development | Sell | S | 12.36 | 4,602 | 56,881 | 0 | 4.6 K to 0 (-100.00 %) |
| Aug 29 2014 | GNCA | GENOCEA BIOSCIENCE ... | Giannasca Paul | VP of Development | Buy | M | 2.86 | 4,602 | 13,162 | 4,602 | 0 to 4.6 K |
| Aug 29 2014 | GNCA | GENOCEA BIOSCIENCE ... | Giannasca Paul | VP of Development | Sell | S | 12.77 | 1,303 | 16,639 | 0 | 1.3 K to 0 (-100.00 %) |
| Aug 29 2014 | GNCA | GENOCEA BIOSCIENCE ... | Giannasca Paul | VP of Development | Buy | M | 2.86 | 1,303 | 3,727 | 1,303 | 0 to 1.3 K |
| Aug 20 2014 | GNCA | GENOCEA BIOSCIENCE ... | HETHERINGTON SETH V | Chief Medical Offic ... | Option Exercise | M | 2.02 | 11,000 | 22,220 | 2,989 | |
| Aug 20 2014 | GNCA | GENOCEA BIOSCIENCE ... | HETHERINGTON SETH V | Chief Medical Offic ... | Buy | M | 2.02 | 11,000 | 22,220 | 11,000 | 0 to 11 K |
| Aug 15 2014 | GNCA | GENOCEA BIOSCIENCE ... | Polaris Venture Management Co. ... | 10% Owner | Sell | S | 13.01 | 6,755 | 87,883 | 2,055,228 | 2.1 M to 2.1 M (-0.33 %) |
| Aug 15 2014 | GNCA | GENOCEA BIOSCIENCE ... | Polaris Venture Management Co. ... | 10% Owner | Sell | S | 13.00 | 2,905 | 37,765 | 2,061,983 | 2.1 M to 2.1 M (-0.14 %) |
| Aug 12 2014 | GNCA | GENOCEA BIOSCIENCE ... | Polaris Venture Management Co. ... | 10% Owner | Sell | S | 13.03 | 20,990 | 273,500 | 2,064,888 | 2.1 M to 2.1 M (-1.01 %) |
| Aug 12 2014 | GNCA | GENOCEA BIOSCIENCE ... | Polaris Venture Management Co. ... | 10% Owner | Sell | S | 13.24 | 1,428 | 18,907 | 2,085,878 | 2.1 M to 2.1 M (-0.07 %) |
| Aug 12 2014 | GNCA | GENOCEA BIOSCIENCE ... | Polaris Venture Management Co. ... | 10% Owner | Sell | S | 13.41 | 41,376 | 554,852 | 2,087,306 | 2.1 M to 2.1 M (-1.94 %) |
| Feb 24 2014 | GNCA | GENOCEA BIOSCIENCE ... | Giannasca Paul | VP of Development | Option Exercise | A | 12.10 | 6,191 | 74,911 | 6,191 | |
| Feb 24 2014 | GNCA | GENOCEA BIOSCIENCE ... | Flechtner Jessica Baker | VP of Research | Option Exercise | A | 12.10 | 14,397 | 174,204 | 14,397 | |
| Feb 24 2014 | GNCA | GENOCEA BIOSCIENCE ... | Farrell Robert E Jr | VP of Finance & Adm ... | Option Exercise | A | 12.10 | 17,019 | 205,930 | 17,019 | |
| Feb 12 2014 | GNCA | GENOCEA BIOSCIENCE ... | GLAXOSMITHKLINE PLC | Option Exercise | C | 0.00 | 4,851,958 | 0 | 0 | ||
| Feb 12 2014 | GNCA | GENOCEA BIOSCIENCE ... | GLAXOSMITHKLINE PLC | Option Exercise | C | 0.00 | 4,099,231 | 0 | 0 | ||
| Feb 12 2014 | GNCA | GENOCEA BIOSCIENCE ... | GLAXOSMITHKLINE PLC | Option Exercise | C | 0.00 | 9,230,769 | 0 | 0 | ||
| Feb 12 2014 | GNCA | GENOCEA BIOSCIENCE ... | GLAXOSMITHKLINE PLC | Buy | C | 0.00 | 407,727 | 0 | 1,671,667 | 1.3 M to 1.7 M (+32.26 %) | |
| Feb 12 2014 | GNCA | GENOCEA BIOSCIENCE ... | GLAXOSMITHKLINE PLC | Buy | C | 0.00 | 344,473 | 0 | 1,263,940 | 919.5 K to 1.3 M (+37.46 %) | |
| Feb 12 2014 | GNCA | GENOCEA BIOSCIENCE ... | GLAXOSMITHKLINE PLC | Buy | C | 0.00 | 775,694 | 0 | 919,467 | 143.8 K to 919.5 K (+539.53 %) | |
| Feb 12 2014 | GNCA | GENOCEA BIOSCIENCE ... | GLAXOSMITHKLINE PLC | Buy | P | 12.00 | 143,773 | 1,725,276 | 143,773 | 0 to 143.8 K | |
| Feb 11 2014 | GNCA | GENOCEA BIOSCIENCE ... | Polaris Venture Management Co. ... | 10% Owner | Option Exercise | X | 0.00 | 399,909 | 0 | 0 | |
| Feb 11 2014 | GNCA | GENOCEA BIOSCIENCE ... | Polaris Venture Management Co. ... | 10% Owner | Option Exercise | C | 0.00 | 6,075,152 | 0 | 0 | |
| Feb 11 2014 | GNCA | GENOCEA BIOSCIENCE ... | Polaris Venture Management Co. ... | 10% Owner | Option Exercise | C | 0.00 | 5,836,663 | 0 | 0 | |
| Feb 11 2014 | GNCA | GENOCEA BIOSCIENCE ... | Polaris Venture Management Co. ... | 10% Owner | Option Exercise | C | 0.00 | 8,393,754 | 0 | 0 | |
| Feb 11 2014 | GNCA | GENOCEA BIOSCIENCE ... | Polaris Venture Management Co. ... | 10% Owner | Option Exercise | C | 0.00 | 2,126,923 | 0 | 0 | |
| Feb 11 2014 | GNCA | GENOCEA BIOSCIENCE ... | Polaris Venture Management Co. ... | 10% Owner | Buy | P | 12.00 | 232,820 | 2,793,840 | 2,128,678 | 1.9 M to 2.1 M (+12.28 %) |
| Feb 11 2014 | GNCA | GENOCEA BIOSCIENCE ... | Polaris Venture Management Co. ... | 10% Owner | Buy | C | 0.00 | 10,781 | 0 | 1,895,858 | 1.9 M to 1.9 M (+0.57 %) |
| Feb 11 2014 | GNCA | GENOCEA BIOSCIENCE ... | Polaris Venture Management Co. ... | 10% Owner | Buy | C | 0.00 | 510,516 | 0 | 1,885,077 | 1.4 M to 1.9 M (+37.14 %) |
| Feb 11 2014 | GNCA | GENOCEA BIOSCIENCE ... | Polaris Venture Management Co. ... | 10% Owner | Buy | C | 0.00 | 490,474 | 0 | 1,374,561 | 884.1 K to 1.4 M (+55.48 %) |
| Feb 11 2014 | GNCA | GENOCEA BIOSCIENCE ... | Polaris Venture Management Co. ... | 10% Owner | Buy | C | 0.00 | 705,356 | 0 | 884,087 | 178.7 K to 884.1 K (+394.65 %) |
| Feb 11 2014 | GNCA | GENOCEA BIOSCIENCE ... | Polaris Venture Management Co. ... | 10% Owner | Buy | C | 0.00 | 178,731 | 0 | 178,731 | 0 to 178.7 K |
| Feb 11 2014 | GNCA | GENOCEA BIOSCIENCE ... | Bitterman Kevin | Director | Option Exercise | X | 0.00 | 399,909 | 0 | 0 | |
| Feb 11 2014 | GNCA | GENOCEA BIOSCIENCE ... | Bitterman Kevin | Director | Option Exercise | C | 0.00 | 6,075,152 | 0 | 0 | |
| Feb 11 2014 | GNCA | GENOCEA BIOSCIENCE ... | Bitterman Kevin | Director | Option Exercise | C | 0.00 | 5,836,663 | 0 | 0 | |
| Feb 11 2014 | GNCA | GENOCEA BIOSCIENCE ... | Bitterman Kevin | Director | Option Exercise | C | 0.00 | 8,393,754 | 0 | 0 | |
| Feb 11 2014 | GNCA | GENOCEA BIOSCIENCE ... | Bitterman Kevin | Director | Option Exercise | C | 0.00 | 2,126,923 | 0 | 0 | |
| Feb 11 2014 | GNCA | GENOCEA BIOSCIENCE ... | Bitterman Kevin | Director | Buy | P | 12.00 | 232,820 | 2,793,840 | 2,128,678 | 1.9 M to 2.1 M (+12.28 %) |
| Feb 11 2014 | GNCA | GENOCEA BIOSCIENCE ... | Bitterman Kevin | Director | Buy | C | 0.00 | 10,781 | 0 | 1,895,858 | 1.9 M to 1.9 M (+0.57 %) |
| Feb 11 2014 | GNCA | GENOCEA BIOSCIENCE ... | Bitterman Kevin | Director | Buy | C | 0.00 | 510,516 | 0 | 1,885,077 | 1.4 M to 1.9 M (+37.14 %) |
| Feb 11 2014 | GNCA | GENOCEA BIOSCIENCE ... | Bitterman Kevin | Director | Buy | C | 0.00 | 490,474 | 0 | 1,374,561 | 884.1 K to 1.4 M (+55.48 %) |
| Feb 11 2014 | GNCA | GENOCEA BIOSCIENCE ... | Bitterman Kevin | Director | Buy | C | 0.00 | 705,356 | 0 | 884,087 | 178.7 K to 884.1 K (+394.65 %) |
| Feb 11 2014 | GNCA | GENOCEA BIOSCIENCE ... | Bitterman Kevin | Director | Buy | C | 0.00 | 178,731 | 0 | 178,731 | 0 to 178.7 K |
| Feb 11 2014 | GNCA | GENOCEA BIOSCIENCE ... | Lux Capital Management, LLC | Option Exercise | X | 0.00 | 587,931 | 0 | 0 | ||
| Feb 11 2014 | GNCA | GENOCEA BIOSCIENCE ... | Lux Capital Management, LLC | Option Exercise | C | 0.00 | 5,099,196 | 0 | 0 | ||
| Feb 11 2014 | GNCA | GENOCEA BIOSCIENCE ... | Lux Capital Management, LLC | Option Exercise | C | 0.00 | 3,207,794 | 0 | 0 | ||
| Feb 11 2014 | GNCA | GENOCEA BIOSCIENCE ... | Lux Capital Management, LLC | Option Exercise | C | 0.00 | 8,393,754 | 0 | 0 | ||
| Feb 11 2014 | GNCA | GENOCEA BIOSCIENCE ... | Lux Capital Management, LLC | Option Exercise | C | 0.00 | 2,126,923 | 0 | 0 | ||
| Feb 11 2014 | GNCA | GENOCEA BIOSCIENCE ... | Lux Capital Management, LLC | Buy | X | 0.00 | 15,852 | 0 | 1,682,037 | 1.7 M to 1.7 M (+0.95 %) | |
| Feb 11 2014 | GNCA | GENOCEA BIOSCIENCE ... | Lux Capital Management, LLC | Buy | C | 0.00 | 428,502 | 0 | 1,666,185 | 1.2 M to 1.7 M (+34.62 %) | |
| Feb 11 2014 | GNCA | GENOCEA BIOSCIENCE ... | Lux Capital Management, LLC | Buy | C | 0.00 | 269,561 | 0 | 1,237,683 | 968.1 K to 1.2 M (+27.84 %) | |
| Feb 11 2014 | GNCA | GENOCEA BIOSCIENCE ... | Lux Capital Management, LLC | Buy | C | 0.00 | 705,357 | 0 | 968,122 | 262.8 K to 968.1 K (+268.44 %) | |
| Feb 11 2014 | GNCA | GENOCEA BIOSCIENCE ... | Lux Capital Management, LLC | Buy | C | 0.00 | 178,732 | 0 | 262,765 | 84 K to 262.8 K (+212.69 %) | |
| Feb 11 2014 | GNCA | GENOCEA BIOSCIENCE ... | George Simeon | Director | Option Exercise | C | 0.00 | 4,851,958 | 0 | 0 | |
| Feb 11 2014 | GNCA | GENOCEA BIOSCIENCE ... | George Simeon | Director | Option Exercise | C | 0.00 | 4,099,231 | 0 | 0 | |
| Feb 11 2014 | GNCA | GENOCEA BIOSCIENCE ... | George Simeon | Director | Option Exercise | C | 0.00 | 9,230,769 | 0 | 0 | |
| Feb 11 2014 | GNCA | GENOCEA BIOSCIENCE ... | George Simeon | Director | Buy | C | 0.00 | 407,727 | 0 | 1,671,667 | 1.3 M to 1.7 M (+32.26 %) |
| Feb 11 2014 | GNCA | GENOCEA BIOSCIENCE ... | George Simeon | Director | Buy | C | 0.00 | 344,473 | 0 | 1,263,940 | 919.5 K to 1.3 M (+37.46 %) |
| Feb 11 2014 | GNCA | GENOCEA BIOSCIENCE ... | George Simeon | Director | Buy | C | 0.00 | 775,694 | 0 | 919,467 | 143.8 K to 919.5 K (+539.53 %) |
| Feb 11 2014 | GNCA | GENOCEA BIOSCIENCE ... | George Simeon | Director | Buy | P | 12.00 | 143,773 | 1,725,276 | 143,773 | 0 to 143.8 K |
| Feb 11 2014 | GNCA | GENOCEA BIOSCIENCE ... | HOFFMAN STEPHEN J | Director | Option Exercise | C | 0.00 | 3,140,414 | 0 | 0 | |
| Feb 11 2014 | GNCA | GENOCEA BIOSCIENCE ... | HOFFMAN STEPHEN J | Director | Option Exercise | C | 0.00 | 9,253,255 | 0 | 0 | |
| Feb 11 2014 | GNCA | GENOCEA BIOSCIENCE ... | HOFFMAN STEPHEN J | Director | Buy | P | 12.00 | 250,931 | 3,011,172 | 1,292,415 | 1 M to 1.3 M (+24.09 %) |
| Feb 11 2014 | GNCA | GENOCEA BIOSCIENCE ... | HOFFMAN STEPHEN J | Director | Buy | C | 0.00 | 263,900 | 0 | 1,041,484 | 777.6 K to 1 M (+33.94 %) |
| Feb 11 2014 | GNCA | GENOCEA BIOSCIENCE ... | HOFFMAN STEPHEN J | Director | Buy | C | 0.00 | 777,584 | 0 | 777,584 | 0 to 777.6 K |
| Feb 11 2014 | GNCA | GENOCEA BIOSCIENCE ... | Clark William D | President and CEO | Option Exercise | A | 3.45 | 81,670 | 281,762 | 81,670 | |
| Feb 11 2014 | GNCA | GENOCEA BIOSCIENCE ... | Siber George | Director | Option Exercise | A | 3.45 | 13,568 | 46,810 | 13,568 | |
| Feb 11 2014 | GNCA | GENOCEA BIOSCIENCE ... | JOHNSON & JOHNSON | 10% Owner | Option Exercise | C | 0.00 | 351,866 | 0 | 0 | |
| Feb 11 2014 | GNCA | GENOCEA BIOSCIENCE ... | JOHNSON & JOHNSON | 10% Owner | Option Exercise | C | 0.00 | 827,917 | 0 | 0 | |
| Feb 11 2014 | GNCA | GENOCEA BIOSCIENCE ... | JOHNSON & JOHNSON | 10% Owner | Buy | C | 0.00 | 1,388,645 | 0 | 1,388,645 | 0 to 1.4 M |
| Feb 06 2014 | GNCA | GENOCEA BIOSCIENCE ... | Giannasca Paul | VP of Development | Option Exercise | A | 12.00 | 12,236 | 146,832 | 12,236 | |
| Feb 06 2014 | GNCA | GENOCEA BIOSCIENCE ... | Flechtner Jessica Baker | VP of Research | Option Exercise | A | 12.00 | 11,402 | 136,824 | 11,402 | |
| Feb 06 2014 | GNCA | GENOCEA BIOSCIENCE ... | Farrell Robert E Jr | VP of Finance & Adm ... | Option Exercise | A | 12.00 | 1,409 | 16,908 | 1,409 |